Shares of Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF – Get Free Report) (TSE:CPH) crossed above its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $6.15 and traded as high as $6.90. Cipher Pharmaceuticals shares last traded at $6.75, with a volume of 6,000 shares traded.
Cipher Pharmaceuticals Price Performance
The firm has a 50-day moving average price of $6.15 and a 200-day moving average price of $5.00.
About Cipher Pharmaceuticals
Cipher Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. It offers Epuris (isotretinoin), an oral retinoid indicated for the treatment of severe nodular and/or inflammatory acne, acne conglobate, and recalcitrant acne; Actikerall, a topical solution indicated for the treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis (Grade I/II) of the face, forehead, and balding scalp; Ozanex for the topical treatment of impetigo; Vaniqa, a topical cream for the slowing of the growth of unwanted facial hair in women; Durela, an opioid analgesic for the management of moderate to moderately severe pain in adults; Brinavess for the rapid conversion of onset atrial fibriallation to sinus rhythm in adults; and Aggrastat, a reversible GP IIb/IIIa inhibitor for use in patients with Acute Coronary Syndrome.
Read More
- Five stocks we like better than Cipher Pharmaceuticals
- What Does a Stock Split Mean?
- Garmin Navigates to New Highs Driven By Wearables Trend
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Cipher Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cipher Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.